FDA Panel Votes to Modify Isotretinoin iPLEDGE REMS

Advisory committee members voted to recommend changing the 19-day lockout for the drug for severe, nodular acne and the monthly attestation requirement for counseling people who cannot get pregnant.

Related Keywords

San Francisco ,California ,United States ,Minnesota ,Megha Tollefson ,Ken Katz ,Kaiser Permanente ,Ophthalmic Drugs Advisory Committee ,Risk Management Advisory Committee ,Drug Administration ,Mitigation Strategy ,Mayo Clinic ,Patient Safety ,Isotretinoin ,Acne ,Acne Vulgaris ,Skin And Soft Tissue Infection ,Pregnancy ,Risk Evaluation And Mitigation Strategies Rems ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,